Viewing Study NCT00119366


Ignite Creation Date: 2025-12-24 @ 4:34 PM
Ignite Modification Date: 2026-04-09 @ 11:43 AM
Study NCT ID: NCT00119366
Status: TERMINATED
Last Update Posted: 2022-12-12
First Post: 2005-07-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
Sponsor: Fred Hutchinson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities View
None Adult Acute Myeloid Leukemia With Del(5q) View
None Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) View
None Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) View
None Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) View
None Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) View
None Childhood Myelodysplastic Syndromes View
None Chronic Myelomonocytic Leukemia View
None Previously Treated Myelodysplastic Syndromes View
None Recurrent Adult Acute Myeloid Leukemia View
None Recurrent Childhood Acute Myeloid Leukemia View
None Refractory Anemia With Excess Blasts View
None Refractory Anemia With Excess Blasts in Transformation View
None Refractory Anemia With Ringed Sideroblasts View
None Refractory Cytopenia With Multilineage Dysplasia View
None Secondary Acute Myeloid Leukemia View
None Secondary Myelodysplastic Syndromes View
Keywords: